Singapore greenlights clinical trials for vaccine candidate developed by Arcturus and Duke-NUS Medical School
- Current Affairs
Singapore greenlights clinical trials for vaccine candidate developed by Arcturus and Duke-NUS Medical School
Singapore’s Health Sciences Authority has affirmed clinical preliminaries for a coronavirus antibody competitor being created by Arcturus Therapeutics and Duke-NUS…
Read More »
